Screening for Presymptomatic Disease

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1991 Jul 1

PMID 1856283

Citations 5

Authors

F V FLYNN

Affiliations

Soon will be listed here.

Citing Articles

C-Reactive Protein as a Marker of Inflammation in Children and Adolescents with Metabolic Syndrome: A Systematic Review and Meta-Analysis.

Podeanu M, Turcu-Stiolica A, Subtirelu M, Stepan M, Ionele C, Gheonea D Biomedicines. 2023; 11(11).

PMID: 38001962 PMC: 10669638. DOI: 10.3390/biomedicines11112961.

Associations between metabolic syndrome components and markers of inflammation in Welsh school children.

Thomas N, Rowe D, Murtagh E, Stephens J, Williams R Eur J Pediatr. 2017; 177(3):409-417.

PMID: 29273941 PMC: 5816764. DOI: 10.1007/s00431-017-3065-y.

Conceptual issues for screening in the genomic era - time for an update?.

Wright C, Zimmern R Epidemiol Biostat Public Health. 2016; 11(4).

PMID: 26973821 PMC: 4783824. DOI: 10.2427/9944.

Testing for hepatitis C virus in Italy.

Dorizzi R, Schiavon R, Disperati A, Capuzzo E, Piccoli P BMJ. 1991; 303(6813):1331.

PMID: 1660746 PMC: 1671409. DOI: 10.1136/bmj.303.6813.1331-b.

The changing practice of pathology.

Shinton N J Clin Pathol. 1992; 45(10):845-9.

PMID: 1430253 PMC: 495051. DOI: 10.1136/jcp.45.10.845.

References

Smith W, Kenicer M, Davis A, Evans A, Yarnell J . Blood cholesterol: is population screening warranted in the UK?. Lancet. 1989; 1(8634):372-3. DOI: 10.1016/s0140-6736(89)91736-4. View

Khaw K, Rose G . Cholesterol screening programmes: how much potential benefit?. BMJ. 1989; 299(6699):606-7. PMC: 1837473. DOI: 10.1136/bmj.299.6699.606. View

Villard L, Murphy M, Vessey M . Cervical cancer deaths in young women. Lancet. 1989; 1(8634):377. DOI: 10.1016/s0140-6736(89)91743-1. View

Tunstall-Pedoe H, Smith W, Tavendale R . How-often-that-high graphs of serum cholesterol. Findings from the Scottish Heart Health and Scottish MONICA studies. Lancet. 1989; 1(8637):540-2. DOI: 10.1016/s0140-6736(89)90077-9. View

McCormick J . Cervical smears: a questionable practice?. Lancet. 1989; 2(8656):207-9. DOI: 10.1016/s0140-6736(89)90384-x. View

Gray J, Chamberlain J . Cervical screening management. Lancet. 1989; 2(8657):280. DOI: 10.1016/s0140-6736(89)90468-6. View

Martin M, Hulley S, Browner W, Kuller L, Wentworth D . Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986; 2(8513):933-6. DOI: 10.1016/s0140-6736(86)90597-0. View

Grant D, Smith I . Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. Br Med J (Clin Res Ed). 1988; 296(6633):1355-8. PMC: 2545827. DOI: 10.1136/bmj.296.6633.1355. View

Mann J, Lewis B, Shepherd J, Winder A, Fenster S, Rose L . Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed). 1988; 296(6638):1702-6. PMC: 2546090. DOI: 10.1136/bmj.296.6638.1702. View

10.

Morgan A . Is routine urine testing in outpatient clinics useful?. BMJ. 1988; 297(6657):1173. PMC: 1835042. DOI: 10.1136/bmj.297.6657.1173. View

11.

Rastam L, Luepker R, Pirie P . Effect of screening and referral on follow-up and treatment of high blood cholesterol levels. Am J Prev Med. 1988; 4(5):244-8. View

12.

Kromhout D, Bosschieter E, Drijver M, de Lezenne Coulander C . Serum cholesterol and 25-year incidence of and mortality from myocardial infarction and cancer. The Zutphen Study. Arch Intern Med. 1988; 148(5):1051-5. View

13.

BELSEY R, Vandenbark M, Goitein R, Baer D . Evaluation of a laboratory system intended for use in physicians' offices. II. Reliability of results produced by health care workers without formal or professional laboratory training. JAMA. 1987; 258(3):357-61. View

14.

Koch T, Mehta U, Lee H, Aziz K, Temel S, Donlon J . Bias and precision of cholesterol analysis by physician's office analyzers. Clin Chem. 1987; 33(12):2262-7. View

15.

Bradwell A, Carmalt M, Whitehead T . Explaining the unexpected abnormal results of biochemical profile investigations. Lancet. 1974; 2(7888):1071-4. DOI: 10.1016/s0140-6736(74)92166-7. View

16.

Randall K . Cancer screening by cytology. Lancet. 1974; 2(7892):1303-4. DOI: 10.1016/s0140-6736(74)90156-1. View

17.

Knox E . Multiphasic screening. Lancet. 1974; 2(7894):1434-6. DOI: 10.1016/s0140-6736(74)90086-5. View

18.

Schoen I, Brooks S . Judgment based on 95 per cent confidence limits: a statistical dilemma involving multitest screening and proficiency testing of multiple specimens. Am J Clin Pathol. 1970; 53(2):190-3. DOI: 10.1093/ajcp/53.2.190. View

19.

Feinleib M, Zelen M . Some pitfalls in the evaluation of screening programs. Arch Environ Health. 1969; 19(3):412-5. DOI: 10.1080/00039896.1969.10666863. View

20.

Feinstein A . Symptoms as an index of biological behaviour and prognosis in human cancer. Nature. 1966; 209(5020):241-5. DOI: 10.1038/209241a0. View